The prevalence of the non-alcoholic fatty liver disease has reached major proportions, being
estimated to affect one-quarter of the global population. The reference techniques, which …

Background: Lifestyle intervention is considered first-line therapy for Nonalcoholic Fatty
Liver Disease (NAFL). Objectives: Here, we aimed to compare the effect of combined …

Prevalence and risk factor analysis for the nonalcoholic fat... : Medicine Prevalence and risk
factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus …

Background: We aimed to assess the association between red cell distribution width-to-
platelet ratio (RPR) and hepatic fibrosis in nonalcoholic fatty liver disease. Methods: The 388 …

Increased red cell width distribution to lymphocyte ratio is... : Medicine Increased red cell width
distribution to lymphocyte ratio is a predictor of histologic severity in primary biliary cholangitis …

Detection of the chronic kidney disease (CKD) progression can begin early intervention to
improve the prognosis of severe non-alcoholic fatty liver disease (NAFLD). This bi …

Small dense low-density lipoprotein (sdLDL) is a distinct low-density lipoprotein (LDL)
cholesterol subclass that has been reported to be associated with metabolic disease. On the …

Background: The prevalence of non-alcoholic fatty liver disease (NAFLD) has increased in
recent decades. There are some concerns about the efficacy and side effects of drugs used …

Background: During the last decade, lifestyle changes considerably leading to an increase
in non-communicable diseases such as nonalcoholic fatty liver disease (NAFLD) accounted …

Background: Chemotherapy is one of the fundamental treatments for cancer patients, which
has significantly improved the survival rate. Alongside its benefits, many side effects are …